New Research Supports CyberKnife for Neurological Disease Treatment

Two studies recently presented at the annual meeting of the European Association of Neurosurgical Societies (EANS) reinforced the benefits of stereotactic radiosurgery (SRS) for neurological diseases, using the CyberKnife^® system.

Dr. Alfredo Conti from the University Hospital of Messina in Italy used CyberKnife in one study to treat perioptic meningioma, a type of benign tumor that arises from the membranes that surround the brain and spinal cord. The noninvasive CyberKnife treatment approach preserved vision while maintaining tumor control within 64 patients treated in 2-5 treatment sessions.

The second study, led by Prof. Pantaleo Romanelli, evaluated the benefits of the CyberKnife system to treat patients with trigeminal neuralgia, a nerve disorder characterized by chronic facial pain. The study evaluated the treatment of 103 patients. After six months, more than 90 percent of patients showed significant improvement in their symptoms. CyberKnife was also used to successfully retreat 24 patients who had relapsed within two years from their first treatment.

For more information on CyberKnife treatment for meningiomas or trigeminal neuralgia, view our conditions treated page. And if you or a loved one has been diagnosed with a type of brain tumor or has been living with the agonizing pain of trigeminal neuralgia, contact Louisville CyberKnife to learn more about CyberKnife treatment for these and other conditions. 

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.